AI Article Synopsis
- Financial incentives can enhance adherence to antiretroviral treatment for people living with HIV, but there are ethical concerns about commodifying healthcare.
- The study involved qualitative interviews and analysis of organizational processes to evaluate the ethical implications of these financial incentives.
- Results indicated that using financial incentives ethically supports client empowerment, improves organizational focus on treatment adherence, and promotes resource fairness.
Article Abstract
Background: Financial incentives have been shown to improve antiretroviral (ARV) adherence for people living with HIV, but scholars have argued that this commodifies treatment and have debated the ethics of doing so. This article summarizes research on ethical processes and factors involved in an intervention that successfully improved ARV adherence among socially vulnerable people living with HIV.
Methods: Thirty qualitative interviews were conducted with intervention participants and field notes documenting organizational processes were analyzed. The protocol utilized a preexisting framework to assess the ethics of using financial incentives to motivate adherence.
Results: Financial incentives supported an ethical service provision framework by (1) establishing and strengthening client agency, (2) revising organizational protocols to prioritize adherence, and (3) promoting resource redistribution.
Conclusions: Financial incentives, when embedded in wrap-around services, innovative client-centered organizational processes, and a justice orientation, constitute an ethical intervention requiring ethical investigation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/amajethics.2021.394 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!